Sareum Holdings
Sareum is a UK-based drug development company, specialising in small molecule kinase inhibitors.
-
Dr Tim Mitchell, CEO, Sareum
Dr Tim Mitchell is CEO of drug discovery company, Sareum, which he co-founded in 2003 and floated on the AIM market of the London Stock Exchange in 2004. Tim has a wide breadth of management, business and research expertise gained over 30 years in biotech, large pharmaceutical and research service companies. Prior to co-founding Sareum, he was Director of Structure-Based Discovery at Millennium Pharmaceuticals, Director of Computational Chemistry at Cambridge Discovery Chemistry, and Team Leader at SmithKline Beecham Pharmaceuticals. Tim has a PhD in Computational Chemistry and a BSc in Chemistry.
